BancorpSouth’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

BancorpSouth’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,681	Closed	-$220K	–	257
2015 Q1	$220K	Sell	5,681 -2,093	-27%	-$80.6K	0.02%	220
2014 Q4	$262K	Hold	7,774	–	–	0.03%	200
2014 Q3	$272K	Buy	7,774 +698	+10%	+$23.9K	0.03%	198
2014 Q2	$233K	Sell	7,076 -1,417	-17%	-$48.5K	0.02%	239
2014 Q1	$313K	Sell	8,493 -812	-9%	-$29.8K	0.03%	190
2013 Q4	$357K	Sell	9,305 -107	-1%	-$3.38K	0.04%	169
2013 Q3	$258K	Buy	+9,412	New	+$223K	0.03%	188

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

BancorpSouth's WX Position: Q2 2015 in Review

BancorpSouth sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2015, closing a stake of 5,681 shares — an estimated $220K sold.

BancorpSouth first reported a position in WX in Q3 2013 and held it in 7 quarters. The position peaked at $357K in Q4 2013. 154 funds tracked by Wall St. Rank hold WX as of Q2 2015.

BancorpSouth reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2015 after selling out during the quarter.
BancorpSouth sold 5,681 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2015, an estimated $220K.
BancorpSouth first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 7 quarters.
BancorpSouth's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $357K in Q4 2013.
154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2015.

Based on BancorpSouth's 13F filing for Q2 2015, filed 13 Aug 2015.